| Identification | |
| Name: | Dabigatran etexilate |
| Synonyms: | Ethyl 3-(((2-(((4-((((hexyloxy)carbonyl)amino)iminomethyl)phenyl)amino)methyl)-1-methyl-1H-benzimidazol-5-yl)carbonyl)(pyridin-2-yl)amino)propanoate; |
| CAS: | 211915-06-9 |
| Molecular Formula: | C34H41N7O5 |
| Molecular Weight: | 627.74 |
| InChI: | InChI=1/C34H41N7O5/c1-4-6-7-10-21-46-34(44)39-32(35)24-12-15-26(16-13-24)37-23-30-38-27-22-25(14-17-28(27)40(30)3)33(43)41(20-18-31(42)45-5-2)29-11-8-9-19-36-29/h8-9,11-17,19,22,37H,4-7,10,18,20-21,23H2,1-3H3,(H2,35,39,44) |
| Molecular Structure: |  |
| Properties | |
| Density: | 1.24 g/cm3 |
| Refractive index: | 1.614 |
| Appearance: | white powder |
| Specification: |
? Dabigatran etexilate , with CAS number of 211915-06-9, can be called Ethyl 3-(((2-(((4-((((hexyloxy)carbonyl)amino)iminomethyl)phenyl)amino)methyl)-1-methyl-1H-benzimidazol-5-yl)carbonyl)(pyridin-2-yl)amino)propanoate ; Pradax ; beta-Alanine, N-((2-(((4-((((hexyloxy)carbonyl)amino)iminomethyl)phenyl)amino)methyl)-1-methyl-1H-benzimidazol-5-yl)carbonyl)-N-2-pyridinyl-, ethyl ester . |
| Safety Data | |
 |
|
